THALASSEMIA
Clinical trials for THALASSEMIA explained in plain language.
Never miss a new study
Get alerted when new THALASSEMIA trials appear
Sign up with your email to follow new studies for THALASSEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Old drugs, new hope: could a thalidomide combo free thalassemia patients from transfusions?
Disease control Not yet recruitingThis study tests whether a combination of two drugs, thalidomide and hydroxyurea, can safely boost fetal hemoglobin levels in people with beta thalassemia major. The goal is to improve overall hemoglobin levels and reduce the need for regular blood transfusions. The trial include…
Matched conditions: THALASSEMIA
Phase: NA • Sponsor: Riphah International University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New hope for thalassemia: drug trial targets anemia without transfusions
Disease control Not yet recruitingThis study tests a new drug called SNH-119014 in 30 adults with a type of thalassemia that does not require regular blood transfusions. The goal is to see if the drug is safe and helps improve anemia. Participants will be monitored for side effects and how their body responds to …
Matched conditions: THALASSEMIA
Phase: PHASE2 • Sponsor: ScinnoHub Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Anemia may skew diabetes test results, new study warns
Knowledge-focused Not yet recruitingThis study looks at how different types of anemia—like iron deficiency or thalassemia—can change HbA1c levels, a common test for diabetes, in people who do not have diabetes. Researchers will compare HbA1c results between 100 non-diabetic adults with various anemias and a healthy…
Matched conditions: THALASSEMIA
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Greek study to measure daily life impact of iron overload drug
Knowledge-focused Not yet recruitingThis study looks at how thalassemia patients in Greece feel day-to-day while taking a standard iron-removing medicine called deferasirox. Researchers will survey 150 adults to measure their physical and mental well-being. The goal is to understand real-world quality of life, not …
Matched conditions: THALASSEMIA
Sponsor: Elpen Pharmaceutical Co. Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC